Literature DB >> 21270770

Astrocyte and glutamate markers in the superficial, deep, and white matter layers of the anterior cingulate gyrus in schizophrenia.

Pavel Katsel1, William Byne, Panos Roussos, Weilun Tan, Larry Siever, Vahram Haroutunian.   

Abstract

Most studies of the neurobiology of schizophrenia have focused on neurotransmitter systems, their receptors, and downstream effectors. Recent evidence suggests that it is no longer tenable to consider neurons and their functions independently of the glia that interact with them. Although astrocytes have been viewed as harbingers of neuronal injury and CNS stress, their principal functions include maintenance of glutamate homeostasis and recycling, mediation of saltatory conduction, and even direct neurotransmission. Results of studies of astrocytes in schizophrenia have been variable, in part because of the assessment of single and not necessarily universal markers and/or assessment of non-discrete brain regions. We used laser capture microdissection to study three distinct partitions of the anterior cingulate gyrus (layers I-III, IV-VI, and the underlying white matter) in the brains of 18 well-characterized persons with schizophrenia and 21 unaffected comparison controls. We studied the mRNA expression of nine specific markers known to be localized to astrocytes. The expression of astrocyte markers was not altered in the superficial layers or the underlying white matter of the cingulate cortex of persons with schizophrenia. However, the expression of some astrocyte markers (diodinase type II, aquaporin-4, S100β, glutaminase, excitatory amino-acid transporter 2, and thrombospondin), but not of others (aldehyde dehydrogenase 1 family member L1, glial fibrillary acidic protein, and vimentin) was significantly reduced in the deep layers of the anterior cingulate gyrus. These findings suggest that a subset of astrocytes localized to specific cortical layers is adversely affected in schizophrenia and raise the possibility of glutamatergic dyshomeostasis in selected neuronal populations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21270770      PMCID: PMC3077461          DOI: 10.1038/npp.2010.252

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  45 in total

1.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.

Authors:  S S Mirra; A Heyman; D McKeel; S M Sumi; B J Crain; L M Brownlee; F S Vogel; J P Hughes; G van Belle; L Berg
Journal:  Neurology       Date:  1991-04       Impact factor: 9.910

2.  Antipsychotic regulation of hippocampal dopamine receptor messenger RNA expression.

Authors:  L M Ritter; J H Meador-Woodruff
Journal:  Biol Psychiatry       Date:  1997-08-01       Impact factor: 13.382

Review 3.  The columnar organization of the neocortex.

Authors:  V B Mountcastle
Journal:  Brain       Date:  1997-04       Impact factor: 13.501

4.  An analysis of the arrangement of neurons in the cingulate cortex of schizophrenic patients.

Authors:  F M Benes; E D Bird
Journal:  Arch Gen Psychiatry       Date:  1987-07

5.  Quantitative study of gliosis in schizophrenia and Huntington's chorea.

Authors:  C D Stevens; L L Altshuler; B Bogerts; P Falkai
Journal:  Biol Psychiatry       Date:  1988-10       Impact factor: 13.382

6.  Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases.

Authors:  D P Purohit; D P Perl; V Haroutunian; P Powchik; M Davidson; K L Davis
Journal:  Arch Gen Psychiatry       Date:  1998-03

7.  Glial fibrillary acidic protein-immunoreactive astrocytosis in elderly patients with schizophrenia and dementia.

Authors:  S E Arnold; B R Franz; J Q Trojanowski; P J Moberg; R E Gur
Journal:  Acta Neuropathol       Date:  1996       Impact factor: 17.088

8.  Cingulate gyrus volume and metabolism in the schizophrenia spectrum.

Authors:  M Mehmet Haznedar; Monte S Buchsbaum; Erin A Hazlett; Lina Shihabuddin; Antonia New; Larry J Siever
Journal:  Schizophr Res       Date:  2004-12-01       Impact factor: 4.939

Review 9.  Thalamic dysfunction in schizophrenia: neurochemical, neuropathological, and in vivo imaging abnormalities.

Authors:  Sarah M Clinton; James H Meador-Woodruff
Journal:  Schizophr Res       Date:  2004-08-01       Impact factor: 4.939

10.  Severity of symptoms in chronically institutionalized geriatric schizophrenic patients.

Authors:  M Davidson; P D Harvey; P Powchik; M Parrella; L White; H Y Knobler; M F Losonczy; R S Keefe; S Katz; E Frecska
Journal:  Am J Psychiatry       Date:  1995-02       Impact factor: 18.112

View more
  34 in total

1.  Association of thrombospondin 1 gene with schizophrenia in Korean population.

Authors:  Hae Jeong Park; Su Kang Kim; Jong Woo Kim; Won Sub Kang; Joo-Ho Chung
Journal:  Mol Biol Rep       Date:  2012-02-07       Impact factor: 2.316

Review 2.  Glutamate dysfunction in hippocampus: relevance of dentate gyrus and CA3 signaling.

Authors:  Carol A Tamminga; Sarah Southcott; Carolyn Sacco; Anthony D Wagner; Subroto Ghose
Journal:  Schizophr Bull       Date:  2012-04-24       Impact factor: 9.306

Review 3.  Glial cells in schizophrenia: a unified hypothesis.

Authors:  Andrea G Dietz; Steven A Goldman; Maiken Nedergaard
Journal:  Lancet Psychiatry       Date:  2019-11-06       Impact factor: 27.083

Review 4.  The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies.

Authors:  Wei Hu; Matthew L MacDonald; Daniel E Elswick; Robert A Sweet
Journal:  Ann N Y Acad Sci       Date:  2014-10-14       Impact factor: 5.691

Review 5.  Role of astrocytic glutamate transporter in alcohol use disorder.

Authors:  Jennifer R Ayers-Ringler; Yun-Fang Jia; Yan-Yan Qiu; Doo-Sup Choi
Journal:  World J Psychiatry       Date:  2016-03-22

6.  Increased density of prohibitin-immunoreactive oligodendrocytes in the dorsolateral prefrontal white matter of subjects with schizophrenia suggests extraneuronal roles for the protein in the disease.

Authors:  Hans-Gert Bernstein; Karl-Heinz Smalla; Diana Dürrschmidt; Gerburg Keilhoff; Henrik Dobrowolny; Johann Steiner; Andrea Schmitt; Michael R Kreutz; Bernhard Bogerts
Journal:  Neuromolecular Med       Date:  2012-06-19       Impact factor: 3.843

Review 7.  (Micro)Glia as Effectors of Cortical Volume Loss in Schizophrenia.

Authors:  Allyson P Mallya; Ariel Y Deutch
Journal:  Schizophr Bull       Date:  2018-08-20       Impact factor: 9.306

Review 8.  Behavioral sequelae of astrocyte dysfunction: focus on animal models of schizophrenia.

Authors:  Meng Xia; Sofya Abazyan; Yan Jouroukhin; Mikhail Pletnikov
Journal:  Schizophr Res       Date:  2014-11-20       Impact factor: 4.939

Review 9.  Biological substrates underpinning diagnosis of major depression.

Authors:  Etienne Sibille; Beverly French
Journal:  Int J Neuropsychopharmacol       Date:  2013-05-14       Impact factor: 5.176

10.  Decreased synaptic and mitochondrial density in the postmortem anterior cingulate cortex in schizophrenia.

Authors:  R C Roberts; K A Barksdale; J K Roche; A C Lahti
Journal:  Schizophr Res       Date:  2015-07-22       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.